PharmGKB summary: peginterferon-α pathway

Pharmacogenet Genomics. 2015 Sep;25(9):465-74. doi: 10.1097/FPC.0000000000000158.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Drug Therapy, Combination
  • Hepacivirus / drug effects
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / genetics
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / pharmacokinetics
  • Interferon-alpha / therapeutic use*
  • Interferons
  • Interleukins / genetics*
  • Polyethylene Glycols / pharmacokinetics
  • Polyethylene Glycols / therapeutic use*
  • Polymorphism, Single Nucleotide
  • Recombinant Proteins / pharmacokinetics
  • Recombinant Proteins / therapeutic use
  • Ribavirin / therapeutic use
  • Treatment Outcome

Substances

  • IFNL3 protein, human
  • Interferon alpha-2
  • Interferon-alpha
  • Interleukins
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • Interferons
  • peginterferon alfa-2b
  • peginterferon alfa-2a